A case of severe hypophosphatemia

Affiliations

¹ School of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
² Division of Nephrology, University of Toronto, Toronto, Canada.
³ Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut Medical Center, Riad El-Solh 1107 2020, Beirut, Lebanon. sk62@aub.edu.lb.

^# Contributed equally.

Case Reports

Nour K Younis et al. J Nephrol. 2021 Dec.

. 2021 Dec;34(6):2117-2121.

doi: 10.1007/s40620-020-00963-2. Epub 2021 Jan 27.

¹ School of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
² Division of Nephrology, University of Toronto, Toronto, Canada.
³ Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut Medical Center, Riad El-Solh 1107 2020, Beirut, Lebanon. sk62@aub.edu.lb.

^# Contributed equally.

No abstract available

Keywords: Aluminum and magnesium hydroxide; Antacids; Hypophosphatemia; Over-the-counter medications; Phosphate metabolism.

References

1. Bergwitz C, Juppner H (2010) Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91–104 - DOI
1. Florenzano P, Cipriani C, Roszko KL, Fukumoto S, Collins MT, Minisola S et al (2020) Approach to patients with hypophosphataemia. Lancet Diabetes Endocrinol 8(2):163–174 - DOI
1. Miller DW, Slovis CM (2000) Hypophosphatemia in the emergency department therapeutics. Am J Emerg Med 18(4):457–461 - DOI
1. Gaasbeek A, Meinders AE (2005) Hypophosphatemia: an update on its etiology and treatment. Am J Med 118(10):1094–1101 - DOI
1. Liamis G, Milionis HJ, Elisaf M (2010) Medication-induced hypophosphatemia: a review. QJM 103(7):449–459 - DOI